Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / Arizona

Peptide legality · Arizona · updated 2026-09-21

Are peptides legal in Arizona?

Gray area

Arizona sits in a gray zone, because the state has no statute or Board of Pharmacy rule that names peptides as a distinct regulated category and instead applies general pharmacy and drug law on top of federal FDA compounding rules.

Legal status overview

Arizona is a gray zone state: no statute, administrative rule, or Board of Pharmacy policy names peptides or research chemicals as a distinct regulated category, so their status is set by general Arizona pharmacy and drug law layered on federal FDA rules. Peptide products that are drugs may only be dispensed under a valid prescription and must be compounded by a licensed pharmacy following Arizona good compounding practices and applicable federal 503A/503B law. A 2026 bill that would have imposed Arizona specific rules on compounded GLP-1 drugs and bulk substances failed to advance, so no peptide specific state statute exists. FDA approved prescription peptide medicines such as Wegovy® (semaglutide) and somatropin remain legal when prescribed properly, and any compounded medication is not FDA-approved; not a generic; not evaluated by the FDA.

Key points

  • Arizona has no statute, administrative rule, or Board of Pharmacy policy that names peptides or research chemicals as a distinct regulated category. [1]
  • Peptide products that are drugs may only be dispensed under a valid prescription and must be compounded by a licensed pharmacy under Arizona good compounding practices in Ariz. Admin. Code section R4-23-410. [3]
  • Arizona compounding is defined and governed under ARS 32-1901 and Title 32 Chapter 18, which frame lawful pharmacy practice in the state. [2]
  • FDA approved prescription peptide drugs remain legal when prescribed and dispensed properly, including Wegovy® (semaglutide) and somatropin. [5]
  • Compounding of semaglutide is no longer permitted now that the FDA has declared the shortage resolved, and compounded semaglutide is not FDA-approved; not a generic; not evaluated by the FDA. [5]
  • The FDA removed BPC-157 from the Category 2 restricted list in 2026 but did not move it to permitted Category 1, and it has no FDA approval or USP monograph, leaving it in a regulatory gray zone. [6]
  • The FDA has flagged BPC-157 as a bulk drug substance that may present significant safety risks in compounding, citing immunogenicity and impurity concerns. [4]
  • Non prescription distribution of human growth hormone, including somatropin, is a federal felony under 21 U.S. Code section 333(e). [7]

Compound-by-compound status

BPC-157
Gray area
Not FDA-approved; not a generic; not evaluated by the FDA. Removed from the Category 2 restricted list in 2026 but not moved to permitted Category 1 and lacking a USP or NF monograph, so it is not authorized for routine 503A compounding.
GLP-1 class (semaglutide, tirzepatide)
Legal
FDA approved brands such as Wegovy® (semaglutide) and Zepbound® (tirzepatide) are legal by valid prescription. Compounded semaglutide is no longer permitted now the shortage is resolved and is not FDA-approved; not a generic; not evaluated by the FDA.
TB-500 (thymosin beta 4)
Restricted
Not FDA-approved; not a generic; not evaluated by the FDA. It lacks a USP or NF monograph and is not on the permitted 503A bulks list, so it is not authorized for compounding.
Growth hormone / somatropin
Legal
FDA approved prescription drug, legal for recognized indications when prescribed. Non prescription distribution is a federal felony under 21 U.S. Code section 333(e).

Frequently asked questions

Are peptides legal in Arizona?

Arizona has no peptide specific ban, so status depends on general pharmacy and drug law plus federal FDA rules. FDA approved prescription peptides are legal when prescribed; unapproved research chemicals sold for human use can be unlawful.

Can an Arizona pharmacy compound BPC-157?

BPC-157 is not FDA-approved and is not on the permitted 503A bulks list, so it is not authorized for routine compounding even after being removed from the Category 2 restricted list. This is information, not legal advice.

Is compounded semaglutide still available in Arizona?

No. With the FDA shortage resolved, routine compounding of semaglutide is not permitted, and any compounded version would be not FDA-approved; not a generic; not evaluated by the FDA.

Did Arizona pass a peptide specific law?

A 2026 bill that would have imposed Arizona specific rules on compounded GLP-1 drugs and bulk substances failed to advance, so no peptide specific state statute is in place.

Is human growth hormone legal in Arizona?

Somatropin is an FDA approved prescription drug and is legal for recognized indications when prescribed. Non prescription distribution is a federal felony under 21 U.S. Code section 333(e).

General information based on the sourced research above, not legal advice. For a specific situation in Arizona, consult a licensed attorney familiar with pharmaceutical law.